Knoll Capital Management as of March 31, 2016
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 22 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Medivation | 82.1 | $202M | 4.4M | 45.98 | |
| Synthetic Biologics | 3.6 | $8.8M | 3.7M | 2.36 | |
| Ampio Pharmaceuticals | 3.1 | $7.6M | 3.4M | 2.25 | |
| Corbus Pharmaceuticals Hldgs | 1.9 | $4.6M | 2.6M | 1.81 | |
| Alcobra | 1.7 | $4.2M | 1.1M | 3.79 | |
| Abeona Therapeutics | 1.4 | $3.5M | 1.4M | 2.56 | |
| Cempra | 1.3 | $3.2M | 181k | 17.52 | |
| Advaxis | 1.0 | $2.5M | 275k | 9.03 | |
| Newlink Genetics Corporation | 0.8 | $1.9M | 102k | 18.20 | |
| Volitionrx (VNRX) | 0.7 | $1.6M | 462k | 3.55 | |
| Vascular Biologics | 0.5 | $1.2M | 333k | 3.48 | |
| Keryx Biopharmaceuticals | 0.4 | $934k | 200k | 4.67 | |
| Ohr Pharmaceutical | 0.3 | $658k | 205k | 3.21 | |
| Advaxis Inc. w exp 07/15/201 | 0.3 | $677k | 113k | 6.02 | |
| Bio Blast Pharma | 0.2 | $625k | 251k | 2.49 | |
| Aldeyra Therapeutics (ALDX) | 0.2 | $569k | 136k | 4.19 | |
| Caladrius Biosciences | 0.2 | $417k | 556k | 0.75 | |
| Champions Oncology (CSBR) | 0.2 | $406k | 111k | 3.65 | |
| Galmed Pharmaceuticals | 0.1 | $320k | 65k | 4.92 | |
| Evoke Pharma | 0.1 | $283k | 56k | 5.08 | |
| Zosano Pharma | 0.0 | $43k | 19k | 2.31 | |
| Aptose Biosciences | 0.0 | $34k | 12k | 2.85 |
